Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia

類似資料

• Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia
  著者:: Byrd, John C., 等
  出版事項: (2007)
• Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule
  著者:: Phelps, Mitch A,, 等
  出版事項: (2008)
• Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias
  著者:: Blum, William, 等
  出版事項: (2010)
• A novel liposomal formulation of flavopiridol
  著者:: Yang, Xiaojuan, 等
  出版事項: (2008)
• Development and Validation of a Highly Sensitive Liquid Chromatography/Mass Spectrometry Method for Simultaneous Quantification of Lenalidomide and Flavopiridol in Human Plasma
  著者:: Liu, Qing, 等
  出版事項: (2008)